Bixiye
P64-20 Update to the Common Carrier and Special Transportation Services Addendums
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2020
Natiijooyinka Raadinta
Soo bandhiga 2391 - 2400 ee natiijooyinka 3701
Bixiye
P66-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2020
Bixiye
QP69-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Risdiplam
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP65-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Satralizumab
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
P48-20 CMS Issued Prior Authorization Requirements for Certain Hospital Outpatient Department (OPD) Services – Effective July 1, 2020
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2020
Bixiye
QP66-20 Updates to Injectable Drug Authorization Requests
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP64-20 Medical Drug Update for New to Market Viltolarsen
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP68-20 MHCP Pharmacy Benefit Update - Eylea®, Iluvien®, Lucentis®, Ozurdex® ,Retisert™ and Yutiq®
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP59-20 MHCP Pharmacy Benefit Exclusion for DurystaTM and Fensolvi®
Taariikhda dhaqangalka Barnaamijka: Jul 08, 2020